497 related articles for article (PubMed ID: 26725058)
1. Function of Autophagy in Nonalcoholic Fatty Liver Disease.
Czaja MJ
Dig Dis Sci; 2016 May; 61(5):1304-13. PubMed ID: 26725058
[TBL] [Abstract][Full Text] [Related]
2. Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth.
Dashti Z; Yousefi Z; Kiani P; Taghizadeh M; Maleki MH; Borji M; Vakili O; Shafiee SM
Metabolism; 2024 May; 154():155811. PubMed ID: 38309690
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Zoller H; Tilg H
Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis and non-alcoholic fatty liver diseases.
Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
[TBL] [Abstract][Full Text] [Related]
5. Autophagy and non-alcoholic fatty liver disease.
Lavallard VJ; Gual P
Biomed Res Int; 2014; 2014():120179. PubMed ID: 25295245
[TBL] [Abstract][Full Text] [Related]
6. [Autophagy and nonalcoholic fatty liver disease].
Li XQ; Wang W; Jia YH; Zhao CY
Zhonghua Gan Zang Bing Za Zhi; 2016 Aug; 24(8):632-635. PubMed ID: 27788715
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.
Dongiovanni P; Romeo S; Valenti L
World J Gastroenterol; 2014 Sep; 20(36):12945-55. PubMed ID: 25278690
[TBL] [Abstract][Full Text] [Related]
8. Autophagy, NAFLD and NAFLD-Related HCC.
Wu WKK; Zhang L; Chan MTV
Adv Exp Med Biol; 2018; 1061():127-138. PubMed ID: 29956211
[TBL] [Abstract][Full Text] [Related]
9. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Fukusato T
World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
[TBL] [Abstract][Full Text] [Related]
10. Autophagy in nonalcoholic steatohepatitis.
Amir M; Czaja MJ
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):159-66. PubMed ID: 21476911
[TBL] [Abstract][Full Text] [Related]
11. Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease.
Nishida N; Yada N; Hagiwara S; Sakurai T; Kitano M; Kudo M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1646-53. PubMed ID: 26875698
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease.
Brunt EM; Wong VW; Nobili V; Day CP; Sookoian S; Maher JJ; Bugianesi E; Sirlin CB; Neuschwander-Tetri BA; Rinella ME
Nat Rev Dis Primers; 2015 Dec; 1():15080. PubMed ID: 27188459
[TBL] [Abstract][Full Text] [Related]
13. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes.
Ma C; Zhang Q; Greten TF
FEBS J; 2018 Feb; 285(4):752-762. PubMed ID: 28857485
[TBL] [Abstract][Full Text] [Related]
15. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.
Jiang CM; Pu CW; Hou YH; Chen Z; Alanazy M; Hebbard L
World J Gastroenterol; 2014 Nov; 20(44):16464-73. PubMed ID: 25469014
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of autophagy acts as a pathogenic mechanism of non-alcoholic fatty liver disease (NAFLD) induced by common environmental pollutants.
Zhang Y; Li K; Kong A; Zhou Y; Chen D; Gu J; Shi H
Ecotoxicol Environ Saf; 2021 Jul; 217():112256. PubMed ID: 33901779
[TBL] [Abstract][Full Text] [Related]
17. Familial non-alcoholic steatohepatitis leading to hepatocellular carcinoma.
Neuman MG; Cohen LB; Malnick S
Chem Biol Interact; 2020 May; 323():109054. PubMed ID: 32217109
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.
Yokohama K; Fukunishi S; Ii M; Nakamura K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
Int J Mol Med; 2016 Nov; 38(5):1499-1506. PubMed ID: 28025996
[TBL] [Abstract][Full Text] [Related]
19. Role of MicroRNAs in the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Zhang C; Wang P; Li Y; Huang C; Ni W; Chen Y; Shi J; Chen G; Hu X; Ye M; Duan S; Wang K
Anat Rec (Hoboken); 2019 Feb; 302(2):193-200. PubMed ID: 30312023
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease.
Gentric G; Maillet V; Paradis V; Couton D; L'Hermitte A; Panasyuk G; Fromenty B; Celton-Morizur S; Desdouets C
J Clin Invest; 2015 Mar; 125(3):981-92. PubMed ID: 25621497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]